文献速递神经创伤神经重症

NLRP3在创伤性脑损伤中的作用及吡格列酮对其的调控

The role of NLRP3 in traumatic brain injury and its regulation by pioglitazone.
PubMed 文献 · J Neurosurg · 2019-09-27

该动物实验在控制性皮层撞击小鼠模型中发现,NLRP3炎症小体参与调控脑水肿与继发性炎症;NLRP3基因敲除或吡格列酮治疗均可减轻脑水肿和免疫反应,提示吡格列酮可能通过下调NLRP3发挥神经保护作用。

要点

  • NLRP3炎症小体是TBI后继发性水肿和炎症的关键调控因子。
  • 吡格列酮可下调NLRP3、IL-1β和caspase-1表达,减轻脑水肿。
  • NLRP3敲除与吡格列酮治疗均降低星形胶质细胞和小胶质细胞活化。

核心结论

  • NLRP3炎症小体在调控脑水肿和继发性炎症中起关键作用,吡格列酮通过下调NLRP3减轻TBI后脑水肿和免疫反应。

研究设计与样本

  • 采用重量打击模型诱导小鼠脑挫伤,设C57BL/6假手术组、NLRP3敲除组和吡格列酮治疗组,比较脑含水量并做Western blot、免疫组化和免疫荧光分析。

主要发现

  • 假手术组TBI后第3天脑水肿最高,敲除组和治疗组脑水肿均低于假手术组。
  • Western blot显示假手术组TBI后炎症小体表达升高,吡格列酮治疗后IL-1β、caspase-1和NLRP3表达显著降低。
  • 敲除组和治疗组GFAP与Iba1表达均降低,共聚焦显微镜显示吡格列酮治疗后小胶质细胞和星形胶质细胞活化减少。

临床怎么用

  • 结果提示吡格列酮可能作为TBI的神经保护策略,但尚需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Perilesional edema is a predominant mechanism underlying secondary brain injury after traumatic brain injury (TBI). Perilesional edema is characterized by inflammation, production of proinflammatory cytokines, and migration of peripheral immune cells into the brain. The nucleotide-binding domain and leucine-rich repeat (NLR) family pyrin domain-containing 3 protein (NLRP3) is a key component of secondary injury. Pioglitazone regulates NLRP3 and other inflammatory cytokines. In the present study, the role of NLRP3 and the pharmacological effects of pioglitazone were investigated in animal TBI models. METHODS: Brain contusion was induced in a weight drop model involving 3 groups of mice: C57 BL/6 (sham group), NLRP3 knockout (K/O group), and pioglitazone-treated mice (treatment group). The percentage of brain water content of the 3 groups of mice was compared over a period of time. Western blot, immunohistochemistry, and immunofluorescence analyses were conducted to investigate NLRP3-related inflammasomes and the effects of pioglitazone in the TBI models. RESULTS: Brain edema was the highest on day 3 after TBI in the sham group. Brain edema in both the K/O and the treatment groups was lower than in the sham group. In Western blot, the expression of inflammasomes was higher after TBI in the sham group, but the expression of interleukin-1β, caspase-1, and NLRP3 was decreased significantly following treatment with pioglitazone. The expression of GFAP (glial fibrillary acidic protein) and Iba1 was decreased in both the K/O and treatment groups. In addition, confocal microscopy revealed a decrease in microglial cell and astrocyte activation following pioglitazone therapy. CONCLUSIONS: The inflammasome NLRP3 plays a pivotal role in regulating cerebral edema and secondary inflammation. Interestingly, pioglitazone reduced cerebral edema and immune response after TBI by downregulating the effects of NLRP3. These results suggest that the clinical application of pioglitazone may be a neuroprotective strategy in TBI.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yi HJ, Lee JE, Lee DH, et al. The role of NLRP3 in traumatic brain injury and its regulation by pioglitazone. J Neurosurg. 2019. PMID: 31561220. doi:10.3171/2019.6.JNS1954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。